Survival of patients with intermediate stage hepatocellular carcinoma treated with superselective transarterial chemoembolization using doxorubicin-loaded DC Bead under cone-beam computed tomography control
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 32: 2557-76.El-SeragHBRudolphKLHepatocellular carcinoma: epidemiology and molecular carcinogenesisGastroenterology20073225577610.1053/j.gastro.2007.04.06117570226Search in Google Scholar
Suk Oh J, Jong Chun H, Gil Choi B, Giu Lee H. Transarterial chemoembolization with drug-eluting bead in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response. J Vasc Interv Radiol 2013; 24: 483-9.Suk OhJJong ChunHGil ChoiBGiu LeeHTransarterial chemoembolization with drug-eluting bead in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor responseJ Vasc Interv Radiol201324483910.1016/j.jvir.2013.01.00123452553Search in Google Scholar
Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-42.LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology2003374294210.1053/jhep.2003.5004712540794Search in Google Scholar
Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-71.LoCMNganHTsoWKLiuCLLamCMPoonRTet alRandomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology20023511647110.1053/jhep.2002.3315611981766Search in Google Scholar
European Association For The Study Of The Liver and European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43.European Association For The Study Of The Liver and European Organisation For Research And Treatment Of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol2012569084310.1016/j.jhep.2011.12.00122424438Search in Google Scholar
Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol 2012; 56: 1330-5.BurrelMReigMFornerABarrufetMde LopeCRTremosiniSet alSurvival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designJ Hepatol2012561330510.1016/j.jhep.2012.01.00822314428Search in Google Scholar
Kim GM, Kim HC, Chung JW, Lee IJ, Kim HM, Jae HJ, et al. Chemoembolization for hepatocellular carcinoma supplied exclusively by the hepatic falciform artery. Cardiovasc Intervent Radiol 2012; 35: 845-51.KimGMKimHCChungJWLeeIJKimHMJaeHJet alChemoembolization for hepatocellular carcinoma supplied exclusively by the hepatic falciform arteryCardiovasc Intervent Radiol2012358455110.1007/s00270-011-0236-521822770Search in Google Scholar
Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33: 41-52.LammerJMalagariKVoglTPilleulFDenysAWatkinsonAet alProspective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V studyCardiovasc Intervent Radiol201033415210.1007/s00270-009-9711-7281679419908093Search in Google Scholar
Lencioni R, Petruzzi P, Crocetti L. Chemoembolization of Hepatocellular Carcinoma. Semin Intervent Radiol 2013; 30: 3-11.LencioniRPetruzziPCrocettiLChemoembolization of Hepatocellular CarcinomaSemin Intervent Radiol20133031110.1053/j.seminoncol.2012.05.00422846867Search in Google Scholar
Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, et al. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 2010; 33: 541-51.MalagariKPomoniMKelekisAPomoniADourakisSSpyridopoulosTet alProspective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinomaCardiovasc Intervent Radiol2010335415110.1007/s00270-009-9750-019937027Search in Google Scholar
Golfieri R, Cappelli A, Cucchetti A, Piscaglia F, Carpenzano M, Peri E, et al. Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (< 5 cm) hepatocellular carcinomas. Hepatology 2011; 53: 1580-9.GolfieriRCappelliACucchettiAPiscagliaFCarpenzanoMPeriEet alEfficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (< 5 cm) hepatocellular carcinomasHepatology2011531580910.1002/hep.2424621351114Search in Google Scholar
Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, et al. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. Am J Roentgenol 2011; 196: 919-28.JinBWangDLewandowskiRJRiazARyuRKSatoKTet alChemoembolization endpoints: effect on survival among patients with hepatocellular carcinomaAm J Roentgenol20111969192810.2214/AJR.10.4770315729121427346Search in Google Scholar
Takayasu K. Superselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspective. Oncology 2011; 81(Suppl 1): 105-10.TakayasuKSuperselective transarterial chemoembolization for hepatocellular carcinoma: recent progression and perspectiveOncology201181Suppl 11051010.1159/00033326922212943Search in Google Scholar
Iwazawa J, Ohue S, Mitani T, Abe H, Hashimoto N, Hamuro M, et al. Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 2009; 192: 1057-63.IwazawaJOhueSMitaniTAbeHHashimotoNHamuroMet alIdentifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiographyAJR Am J Roentgenol200919210576310.2214/AJR.08.128519304714Search in Google Scholar
Higashihara H, Osuga K, Onishi H, Nakamoto A, Tsuboyama T, Maeda N, et al. Diagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCT. Eur Radiol 2012; 22: 872-9.HigashiharaHOsugaKOnishiHNakamotoATsuboyamaTMaedaNet alDiagnostic accuracy of C-arm CT during selective transcatheter angiography for hepatocellular carcinoma: comparison with intravenous contrast-enhanced, biphasic, dynamic MDCTEur Radiol201222872910.1007/s00330-011-2324-y22120061Search in Google Scholar
Loffroy R, Lin M, Yenokyan G, Rao PP, Bhagat N, Noordhoek N, et al. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma? Radiology 2013; 266: 636-48.LoffroyRLinMYenokyanGRaoPPBhagatNNoordhoekNet alIntraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?Radiology20132666364810.1148/radiol.12112316355887623143027Search in Google Scholar
Floridi C, Radaelli A, Abi-Jaoudeh N, et al. C-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applications. Radiol Med 2014; 119: 521-32.FloridiCRadaelliAAbi-JaoudehNet alC-arm cone-beam computed tomography in interventional oncology: technical aspects and clinical applicationsRadiol Med20141195213210.1007/s11547-014-0429-5420996525012472Search in Google Scholar
Tacher V, Radaelli A, Lin M, Geschwind JF. How I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver Cancer. Radiology 2015; 274: 320-34.TacherVRadaelliALinMGeschwindJFHow I Do It: Cone-Beam CT during Transarterial Chemoembolization for Liver CancerRadiology20152743203410.1148/radiol.14131925431429425625741Search in Google Scholar
Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, et al. Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography. Cardiovasc Intervent Radiol 2009; 32: 255-64.MiyayamaSYamashiroMOkudaMYoshieYSugimoriNIgarashiSet alUsefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiographyCardiovasc Intervent Radiol2009322556410.1007/s00270-008-9468-419067043Search in Google Scholar
Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, et al. Comparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤ 6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomography. Cardiovasc Intervent Radiol 2014; 37: 388-95.MiyayamaSYamashiroMHashimotoMHashimotoNIkunoMOkumuraKet alComparison of local control in transcatheter arterial chemoembolization of hepatocellular carcinoma ≤ 6 cm with or without intraprocedural monitoring of the embolized area using cone-beam computed tomographyCardiovasc Intervent Radiol2014373889510.1007/s00270-013-0667-223775550Search in Google Scholar
Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani T. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma. Eur J Radiol 2012; 81: 3985-92.IwazawaJOhueSHashimotoNMuramotoOMitaniTSurvival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinomaEur J Radiol20128139859210.1016/j.ejrad.2012.08.01222959287Search in Google Scholar
Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 52-60.LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis201030526010.1055/s-0030-124713220175033Search in Google Scholar
Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol 2010; 101: 476-80.DhanasekaranRKoobyDAStaleyCAKauhJSKhannaVKimHSComparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)J Surg Oncol20101014768010.1002/jso.2152220213741Search in Google Scholar
Boatta E, Corona M, Cannavale A, Fanelli F, Cirelli C, de Medici L. Endovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatment. Indian J Radiol Imaging 2013; 23: 126-33.BoattaECoronaMCannavaleAFanelliFCirelliCde MediciLEndovascular treatment of hepatocellular carcinoma with drug eluting microparticles (DC-Beads): CT evaluation of response to the treatmentIndian J Radiol Imaging2013231263310.4103/0971-3026.116564377732124082476Search in Google Scholar
Georgiades C, Geschwind JF, Harrison N, Hines-Peralta A, Liapi E, Hong K, et al. Lack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment? Radiology 2012; 265: 115-23.GeorgiadesCGeschwindJFHarrisonNHines-PeraltaALiapiEHongKet alLack of response after initial chemoembolization for hepatocellular carcinoma: does it predict failure of subsequent treatment?Radiology20122651152310.1148/radiol.12112264413778322891361Search in Google Scholar
Lencioni R, Chen XP, Dagher L, Venook AP. Treatment of intermediate/ advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 2010; 4(Suppl 15): 42-52.LencioniRChenXPDagherLVenookAPTreatment of intermediate/ advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?Oncologist20104Suppl 15425210.1634/theoncologist.2010-S4-4221115580Search in Google Scholar
Cabibbo G, Genco C, Di Marco V, Barbara M, Enea M, Parisi P, et al. Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation. Aliment Pharmacol Ther 2011; 34: 196-204.CabibboGGencoCDi MarcoVBarbaraMEneaMParisiPet alPredicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisationAliment Pharmacol Ther20113419620410.1111/j.1365-2036.2011.04694.x21564144Search in Google Scholar
Huang K, Zhou Q, Wang R, Cheng D, Ma Y. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 2014; 29: 920-5.HuangKZhouQWangRChengDMaYDoxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinomaJ Gastroenterol Hepatol201429920510.1111/jgh.1243924224722Search in Google Scholar
Malagari K, Pomoni M, Moschouris H, Bouma E, Koskinas J, Stefaniotou A, et al. Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovasc Intervent Radiol 2012; 35: 1119-28.MalagariKPomoniMMoschourisHBoumaEKoskinasJStefaniotouAet alChemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysisCardiovasc Intervent Radiol20123511192810.1007/s00270-012-0394-022614031Search in Google Scholar
Kim BK, Kim SU, Kim KA, Chung YE, Kim MJ, Park MS, et al. Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma. J Hepatol 2015; 62: 1304-10.KimBKKimSUKimKAChungYEKimMJParkMSet alComplete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinomaJ Hepatol20156213041010.1016/j.jhep.2015.01.02225637785Search in Google Scholar
Zach V, Rapaport B, Yoo JY, Goldfeder L, Weinberger J. Multiple ischemic strokes after transcatheter arterial chemoembolization for hepatocellular carcinoma with a radiographic and pathological correlate. J Stroke Cerebrovasc Dis 2012; 21: 217-24.ZachVRapaportBYooJYGoldfederLWeinbergerJMultiple ischemic strokes after transcatheter arterial chemoembolization for hepatocellular carcinoma with a radiographic and pathological correlateJ Stroke Cerebrovasc Dis2012212172410.1016/j.jstrokecerebrovasdis.2010.08.00121036627Search in Google Scholar
Loffroy R, Favelier S, Cherblanc V, Estivalet L. C-arm dual-phase cone-beam CT: a revolutionary real-time imaging modality to assess drug-eluting beads TACE success in liver cancer patients. Quant Imaging Med Surg 2013; 3: 196-9.LoffroyRFavelierSCherblancVEstivaletLC-arm dual-phase cone-beam CT: a revolutionary real-time imaging modality to assess drug-eluting beads TACE success in liver cancer patientsQuant Imaging Med Surg201331969Search in Google Scholar
Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 2005; 1(Suppl 25): 25-39.KimHCChungJWLeeWJaeHJParkJHRecognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolizationRadiographics20051Suppl 25253910.1148/rg.25si05550816227494Search in Google Scholar
Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 2006; 29: 39-48.MiyayamaSMatsuiOTakiKMinamiTRyuYItoCet alExtrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolizationCardiovasc Intervent Radiol200629394810.1007/s00270-004-0287-y16328697Search in Google Scholar
